Bromide

Bromide

SCHEMBL320962

C[Zn+].[Br-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL392478 0.75
Fluoride Ion SCHEMBL14841650 0.75
Hydrochloric Acid SCHEMBL15863448 0.67
SCHEMBL9067532 0.67
Bromide SCHEMBL1031308 0.50
Water SCHEMBL28822406 0.50
Bromide SCHEMBL4583339 0.50
Bromide SCHEMBL29029405 0.50
Bromide SCHEMBL29377410 0.50
SCHEMBL5383540 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111995883-B Preparation method of metal oxide/hollow microsphere composite filler 中国石油化工股份有限公司 2021-11-09 CN claimed
CN-111995883-A Preparation method of metal oxide/hollow microsphere composite filler 中国石油化工股份有限公司 2020-11-27 CN claimed
EP-2584005-B1 TYPICAL METAL CONTAINING POLYSILOXANE COMPOSITION, PROCESS FOR PRODUCTION OF SAME, AND USES THEREOF TOSOH CORP (JP) 2018-02-21 EP claimed
EP-4720050-A1 PROCESS OF PREPARING HIV CAPSID INHIBITOR GILEAD SCIENCES, INC. (US) 2026-04-08 EP disclosed
WO-2024249672-A1 PROCESS OF PREPARING HIV CAPSID INHIBITOR GILEAD SCIENCES, INC. (US) 2024-12-05 WO disclosed
US-11975301-B2 Method of producing nanoparticles DOW SILICONES CORPORATION (US) 2024-05-07 US disclosed
US-11427598-B2 Spiro-cyclic amine derivatives as S1P modulators AbbVie Deutschland GmbH & Co. KG (DE) 2022-08-30 US disclosed
US-20220176333-A1 METHOD OF PRODUCING NANOPARTICLES DOW SILICONES CORPORATION 2022-06-09 US disclosed
EP-3258929-B1 FACTOR IXA INHIBITORS MERCK SHARP & DOHME (US) 2022-04-27 EP disclosed
EP-3946708-A1 METHOD OF PRODUCING NANOPARTICLES Dow Silicones Corporation (US) 2022-02-09 EP disclosed
CN-111995883-B Preparation method of metal oxide/hollow microsphere composite filler 中国石油化工股份有限公司 2021-11-09 CN disclosed
US-5817828-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS; VISION DEFECTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1998-10-06 US disclosed
US-5721264-A EXHIBIT ANTAGONISTIC EFFECT AGAINST ANGIOTENSIN II; USEFUL FOR PREVENTION AND REMEDY OF HYPERTENSION, CONGESTIVE HEARTFAILURE, CHRONIC RENAL INSUFFICIENCY, ALDOSTERONISM NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1998-02-24 US disclosed
CN-1120837-A Pyrazole derivatives NISSAN CHEMICAL IND LTD (JP) 1996-04-17 CN disclosed
EP-0693480-A1 PYRAZOLE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1996-01-24 EP disclosed
EP-0337765-B1 ACYLSULFONAMIDE DERIVATIVES OF ALPHA-CARBOCYCLYLTOLUIC ACIDS USED AS LEUKOTRIENE ANTAGONISTS ICI AMERICAS INC. (US) 1992-10-14 EP disclosed
CN-1063869-A New nitrogenous bicyclic derivatives, its preparation method, the new intermediate that obtains thus, its pharmaceutical use and the pharmaceutical composition that contains this class material ROUSSEL UCLAF (FR) 1992-08-26 CN disclosed
US-5095038-A Antiinflammatory, antiallergens ICI AMERICAS INC. (US) 1992-03-10 US disclosed
EP-0337765-A2 Acylsulfonamide derivatives of alpha-carbocyclyltoluic acids used as leukotriene antagonists ICI AMERICAS INC. (US) 1989-10-18 EP disclosed
US-4603171-A ANTIONIC CATALYSTS PHILLIPS PETROLEUM COMPANY (US) 1986-07-29 US disclosed